Further pharmacological characterization of bradykinin B1 receptor up- regulation in human umbilical vein

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1019-1025

  Sardi, Sergio Pablo ^a   Daray, Federico Manuel ^a   Errasti, Andrea Emilse ^a   Pelorosso, Facundo German ^a   Pujol Lereis, Virginia Andrea ^a   Rey Ares, Veronica ^a   Rogines Velo, María Pía ^a   Rothlin, Rodolfo Pedro ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; CYCLOHEXIMIDE; DACTINOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA; TUNICAMYCIN;

ARTICLE; CONCENTRATION RESPONSE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; SENSITIZATION; UMBILICAL VEIN;

ANTINEOPLASTIC AGENTS; CYCLOHEXIMIDE; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; HUMANS; PREGNANCY; PYRROLIDINES; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ; RECOMBINANT PROTEINS; THIOCARBAMATES; TUMOR NECROSIS FACTOR-ALPHA; TUNICAMYCIN; UMBILICAL VEINS; UP-REGULATION;

EID: 0032803536     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alberts B, Bray D, Lewis J, Raff M, Roberts K and Watson JD (1984) Basic genetic mechanisms, in Molecular Biology of the Cell (Adams R ed) pp 223-287, Garland Publishing, New York.
2. 1 receptors in isolated rabbit aorta by using metabolic inhibitors. Eur J Pharmacol 271:551-555.
3. Baeuerle PA (1998) IκB-NF-κB structures: At the interface of inflammation control. Cell 95:729-731.
4. Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14:649-681.
5. Bathon JM and Proud D (1991) Bradykinin antagonists. Annu Rev Pharmacol Toxicol 31:129-162.
6. 9-bradykinin in vitro and in vivo. Br J Pharmacol 92:257-264.
7. 2 receptors-mediated rat paw edema by IL-1β and TNFα. Peptides 19:1269-1276.
8. Chabner BA, Allegra CJ, Curt GA and Calabresi P (1996) Antineoplastic agents, in Goodman & Gilman's The Pharmacological Basis of Therapeutics, International Edition (Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Goodman Gilman A eds) pp 1233-1287, McGraw-Hill, New York.
9. De Lean A, Munson PJ and Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102.
10. 9-bradykinin. Br J Pharmacol 93:969-977.
11. 9-braykinin: Possible role of interleukin-1. Br J Pharmacol 103:1057-1066.
12. Elbein AD (1987) Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu Rev Biochem 56:497-534.
13. Elgoyhen AB, Lorenzo PS, Rothlin RP, Spacavento D and Adler-Graschinsky E (1993) Relaxant effects of benzodiazepines on isolated human umbilical arteries and veins. J Auton Pharmacol 13:373-379.
14. 1 receptors: A review. Immunopharmacology 30(Suppl 1):1-26.
15. 1 receptors for kinins. Pharmacol Rev 150:357-386.
16. Marceau F, Lussier A, Regoli D and Giroud JP (1983) Pharmacology of kinins: Their relevance to tissue injury and inflammation. Gen Pharmacol 14(Suppl 2):209-229.
17. 2 bradykinin receptor. Proc Natl Acad Sci U S A 88(Suppl 17):7724-7728.
18. 1 bradykinin receptor. J Biol Chem 269:21583-21586.
19. 1 receptor gene in inflammation. J Biol Chem 273:2784-2791.
20. Rands E, Candelore MR, Cheung AH, Hill WS, Strader CD and Dixon RA (1990) Mutational analysis of beta-adrenergic receptor glycosylation. J Biol Chem 265: 10759-10764.
21. Regoli D, Barabe J and Park WK (1977) Receptors for bradykinin in rabbit aortae. Can J Physiol Pharmacol 55(Suppl 4):855-867.
22. Regoli D, Marceau F and Barabé J (1978) De novo formation of vascular receptors for bradykinin. Can J Physiol Pharmacol 56:674-677.
23. 1 receptors in human umbilical vein. Eur J Pharmacol 321:33-38.
24. 1 receptors in human umbilical vein: Pharmacological evidence of up-regulation, and induction by interleukin-1 beta. Eur J Pharmacol 358:221-227.
25. Schreck R, Meier B, Mannel DN, Droge W and Baeuerle PA (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175:1181-1194.
26. Struck DK and Lennarz WJ (1977) Evidence for the participation of saccharide-lipids in the synthesis of the oligosaccharide chain of ovalbumin. J Biol Chem 252:1007-1013.
27. Tkacz JS and Lampen O (1975) Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes. Biochem Biophys Res Commun 65:248-257.
28. Traenckner EB, Wilk S and Baeuerle PA (1994) A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phoaphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 13:5433-5441.
29. 2 receptor alpha and beta isoforms. J Pharmacol Exp Ther 286:1026-1036.
30. 1 receptor gene expression. Biochem J 330:361-366.